CLINICAL_TRIALS ClinicalTrials.gov record update

A Prospective, Observational Study to Assess the Virological Response at Week 4 to the Therapy With PEGASYS® (Peginterferon Alfa 2a) Plus COPEGUS® (Ribavirin) in a Population of Treatment Naïve Patients With Chronic Hepatitis C, Genotype 2 or 3.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00700401
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:11.301420+00:00
Published At: 2016-06-21T00:00:00+00:00
Record Updated At: 2016-06-21
Results Posted At: 2016-06-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis C, Chronic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-06-21"
protocolSection.identificationModule.nctId: "NCT00700401"
protocolSection.identificationModule.officialTitle: "A Prospective, Observational Study to Assess the Virological Response at Week 4 to the Therapy With PEGASYS\u00ae (Peginterferon Alfa 2a) Plus COPEGUS\u00ae (Ribavirin) in a Population of Treatment Na\u00efve Patients With Chronic Hepatitis C, Genotype 2 or 3."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: []
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2016-06-21"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.